Clinical Trial

Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)

Recruiting
View on ClinicalTrials.gov →
Summary
Background: \- Uveal coloboma is a condition where the eye does not form normally. It occurs early in the fetus s development during pregnancy. It can lead to different kinds of eye problems, including blindness. Uveal coloboma is part of a spectrum of developmental eye conditions that include anophthalmia and microphthalmia, typically referred to as "MAC". Several genes have been linked to MAC, but the cause of most causes are hard to find. Researchers want to study the genes of people who have MAC and genes from their close, unaffected relatives (such as parents and siblings). Objectives: \- To study the genes associated with MAC. Eligibility: \- Individuals at least 1 years of age who either have MAC or are an unaffected relative (such as a parent or sibling). Design: * Participants will have a physical exam and medical history. They will also have a full eye exam. * Participants with MAC may have other exams, such as imaging studies and hearing assessments. * All participants will also provide blood, cheek swab or saliva or DNA samples for genetic testing.
Protocol Amendment History 312 amendments
This ClinicalTrials.gov record has been amended 312 times since 2013-01-26; most recent amendment 2026-07-16.
Trial Details
NCT Number NCT01778543
Lead Sponsor National Eye Institute (NEI)
Conditions Coloboma, Anophthalmia, Microphthalmia
Enrollment 600 participants
Start Date 2013-01-08
Primary Completion 2027-12-27 (estimated)
Updated on ClinicalTrials.gov 2026-08-07